Tag - pharmaceutical

 
 

PHARMACEUTICAL

Kobayashi Pharmaceutical's Tokyo office. An investigation into the cause of the health issues is underway, with partner companies attempting to recall products that could include the batch of beni kōji said to have caused kidney problems.
JAPAN / Science & Health
Apr 4, 2024
Kobayashi Pharma's wide supply chain complicates search for tainted products
Looking at the overall market, one study showed that around 33,000 companies have sold and distributed products using the firm's red yeast rice.
Health ministry officials enter Kobayashi Pharmaceutical's Osaka plant on Saturday for inspection.
JAPAN / Science & Health
Apr 4, 2024
Cause of Kobayashi Pharma health scare still unclear as probe continues
A natural compound derived from blue mold has been detected in the firm's beni kо̄ji supplements, but the substance's health impacts are still unclear.
An official of Kobayashi Pharmaceutical speaks to reporters on Saturday in Osaka following the health ministry's inspections of the firm's plant.
JAPAN / Society
Apr 3, 2024
166 hospitalized over health issues linked to beni kōji
Taiwan's health ministry said the number of people experiencing ill health after taking Kobayashi Pharmaceutical's beni koji had risen to 11 as of Monday.
Kobayashi Pharmaceutical's Tokyo office. The company reported more cases of hospitalization linked to its dietary supplements.
JAPAN / Science & Health
Apr 2, 2024
Kobayashi Pharma's health supplements tied to 157 hospitalizations
The figure reflects an increase from the 114 hospitalization cases that the company said were linked to its products containing red yeast rice.
Beni kо̄ji has been widely used in Japan and elsewhere as a food additive, and features prominently in Okinawan cuisine, particularly in a dish called tо̄fuyо̄.
JAPAN / Society
Apr 1, 2024
Beni kōji purveyors fear growing aversion following supplement scandal
The ingredient has long been used in Japan and elsewhere as a food additive, and features prominently in Okinawan cuisine.
Officials from the health ministry arrive at Kobayashi Pharmaceutical's plant in Kinokawa, Wakayama Prefecture, on Sunday for inspection.
JAPAN / Science & Health
Mar 31, 2024
Kobayashi Pharma plants inspected over health problems
The company said five people have died after taking the supplement so far, with the total number of hospitalized users reaching 114.
Kobayashi Pharmaceutical President Akihiro Kobayashi (second from left) and other executives apologize for the deaths and other health damage associated with its dietary supplements, in the city of Osaka on Friday.
JAPAN / Science & Health
Mar 29, 2024
Kobayashi Pharma says blue mold compound may be cause of health problems
The beni kо̄ji red yeast rice dietary supplements are now linked to five deaths and 114 hospitalizations.
Packs of dietary supplements designated as functional food by Kobayashi Pharmaceutical. Consumer rights groups have for years argued that the functional food label is thin in scientific evidence and potentially harmful to health.
JAPAN / Science & Health
Mar 29, 2024
Kobayashi Pharma scandal reignites debate on ‘functional food’ labels
The labels have been criticized for years over the lack of sufficient scientific proof of safety and efficacy accompanying their use.
According to Yano Research Institute, Japan's supplements market grew about 30% in the span of three years.
BUSINESS
Mar 29, 2024
Supplements market in Japan showing steady growth
Improved health awareness sparked by COVID-19 is a major factor fueling the growth, market research firms say.
Kobayashi Pharmaceutical's Osaka manufacturing facility in the city of Osaka on Wednesday
JAPAN / Science & Health / EXPLAINER
Mar 28, 2024
What we know so far about Kobayashi Pharma's supplement deaths
The Osaka-based drugmaker is finding itself under further scrutiny as the search to pinpoint the cause of the deaths continues.
Kobayashi Pharmaceutical has announced a recall of its products.
JAPAN / Science & Health
Mar 27, 2024
Concerns mount after two deaths linked to Kobayashi Pharma supplement
A government probe is being conducted to establish whether the supplement, which contains beni kо̄ji red fermented rice, led to the deaths.
Akihiro Kobayashi (left), president of major drugmaker Kobayashi Pharmaceutical, speaks to reporters along with other executives in Osaka on Friday.
JAPAN / Science & Health
Mar 24, 2024
Osaka drugmaker recalls dietary supplements linked to kidney disorders
The Osaka-based drugmaker announced Friday that, of the six hospitalized, two suffered symptoms serious enough to require temporary dialysis.
Toshiba went private through a takeover bid after a series of battles with activist shareholders.
BUSINESS / Companies
Jan 21, 2024
Management buyouts by big companies on rise in Japan
The total value of management buyout deals exceeded ¥1.4 trillion in Japan in 2023 to hit a record high.
Buyouts by management and controlling parties have surged this year in Japan, with the total value now set to pass ¥1 trillion.
COMMENTARY / Japan
Dec 3, 2023
Being a listed company in Japan is losing its luster
Japan's corporate landscape is shifting as companies opt for management buyouts.
Japan Times
BUSINESS
Nov 12, 2022
Takeda to seek Japan approval for dengue vaccine
The firm's CEO said Takeda will prioritize regulatory approval in endemic countries, and that it will later seek approval in Japan to make it available for travelers.
Japan Times
ASIA PACIFIC
Apr 23, 2022
Questions over effectiveness of COVID remedy costs top Chinese scientist $2 billion
Debate over the efficacy of traditional Chinese medicine has intensified in recent weeks as the nation fights its worst outbreak since the early days of the pandemic.
Japan Times
BUSINESS
Dec 13, 2021
Billionaire’s bet on Pfizer vaccine for China fails to pay off
Xi Jinping's administration has backed a nationalist agenda on all fronts, including in the fight against the virus.
Japan Times
JAPAN
Oct 1, 2021
Japan's Takeda says 'human error' caused contamination of Moderna vaccines
Japanese authorities in August suspended the use of three batches of Moderna shots containing 1.63 million doses after being notified of the contamination.
Japan Times
BUSINESS / Companies
Oct 22, 2020
Fujifilm works with Shanghai firm to get Avigan approved in China
Fujifilm Holdings Corp. said on Thursday it has partnered with Shanghai-based Carelink Pharmaceutical Co. to seek approval in China for Avigan to treat COVID-19 and influenza.
Japan Times
COMMENTARY / World
Aug 26, 2020
Pharma rivals are fighting COVID-19 together — Why stop there?
Pandemics make for strange bedfellows.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?